These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18776562)

  • 1. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
    Diala I; Murao S; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled intracellular localization and enhanced antisense effect of oligonucleotides by chemical conjugation.
    Kubo T; Zhelev Z; Bakalova R; Ohba H; Doi K; Fujii M
    Org Biomol Chem; 2005 Sep; 3(18):3257-9. PubMed ID: 16132084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly sensitive inhibition of hTERT mRNA expression and telomerase activity by DNA-signal-peptide conjugates.
    Kubo T; Bakalova R; Zhelev Z; Ohba H; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2005; (49):337-8. PubMed ID: 17150771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of phosphorothioate oligonucleotide-peptide conjugates by solid phase fragment condensation.
    Diala I; Osada A; Maruoka S; Imanisi T; Murao S; Ato T; Ohba H; Fujii M
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6576-8. PubMed ID: 17942304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precisely controlled intracellular delivery of DNA-peptide conjugates.
    Kubo T; Kanno K; Rumiana B; Ohba H; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2004; (48):99-100. PubMed ID: 17150497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense effects of DNA-peptide conjugates.
    Kubo T; Bakalova R; Ohba H; Fujii M
    Nucleic Acids Res Suppl; 2003; (3):179-80. PubMed ID: 14510439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
    Grijalvo S; Terrazas M; Aviñó A; Eritja R
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of intracellular delivery of oligonucleotides by signal peptides and genetic expression in human cells.
    Kubo T; Kanno K; Ohba H; Rumiana B; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2004; (48):303-4. PubMed ID: 17150599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human telomerase activity by peptide nucleic acids.
    Norton JC; Piatyszek MA; Wright WE; Shay JW; Corey DR
    Nat Biotechnol; 1996 May; 14(5):615-9. PubMed ID: 9630953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peptide-oligonucleotide conjugates as a new generation of antisense elements].
    Stetsenko DA; Arzumanov AA; Korshun VA; Gait MJ
    Mol Biol (Mosk); 2000; 34(6):998-1006. PubMed ID: 11186016
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties.
    Antopolsky M; Azhayeva E; Tengvall U; Auriola S; Jääskeläinen I; Rönkkö S; Honkakoski P; Urtti A; Lönnberg H; Azhayev A
    Bioconjug Chem; 1999; 10(4):598-606. PubMed ID: 10411457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human telomerase by oligonucleotide chimeras, composed of an antisense moiety and a chemically modified homo-oligonucleotide.
    Tarkanyi I; Horváth A; Szatmari I; Eizert H; Vámosi G; Damjanovich S; Ségal-Bendirdjian E; Aradi J
    FEBS Lett; 2005 Feb; 579(6):1411-6. PubMed ID: 15733850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antisense oligonucleotides with antitumor activity].
    Otvös L; Sági G
    Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro inhibition properties of oligonucleotide conjugates carrying amphipathic proline-rich peptide derivatives of the sweet arrow peptide (SAP).
    Grijalvo S; Eritja R
    Mol Divers; 2012 May; 16(2):307-17. PubMed ID: 22392648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of intracellular delivery and inhibition of genetic expression by DNA-peptide conjugates.
    Kubo T; Anno Y; Yano M; Takamori K; Bakalova R; Ohba H; Fujii M
    Nucleic Acids Res Suppl; 2003; (3):237-8. PubMed ID: 14510468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase inhibition, telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT.
    Diala I; Shiohama Y; Fujita T; Kotake Y; Demonacos C; Krstic-Demonacos M; Leva GD; Fujii M
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):407-425. PubMed ID: 32310030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear localization and antisense effect of PNA internalized by ASGP-R-mediated endocytosis with protein/DNA conjugates.
    Ishihara T; Kano A; Obara K; Saito M; Chen X; Park TG; Akaike T; Maruyama A
    J Control Release; 2011 Oct; 155(1):34-9. PubMed ID: 20955741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotide repress telomerase activity via manipulating alternative splicing or translation.
    Zhou J; Li T; Geng X; Sui L; Wang F
    Biochem Biophys Res Commun; 2021 Dec; 582():118-124. PubMed ID: 34710826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties.
    Chaloin L; Vidal P; Lory P; Méry J; Lautredou N; Divita G; Heitz F
    Biochem Biophys Res Commun; 1998 Feb; 243(2):601-8. PubMed ID: 9480855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cellular uptake and cytotoxicity studies of organometallic bioconjugates of the NLS peptide in Hep G2 cells.
    Noor F; Kinscherf R; Bonaterra GA; Walczak S; Wölfl S; Metzler-Nolte N
    Chembiochem; 2009 Feb; 10(3):493-502. PubMed ID: 19115329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.